Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Howard Spiegel"'
Publikováno v:
Advances in Cosmetic Surgery. 6:89-97
Publikováno v:
Facial Plastic Surgery Clinics of North America.
Autor:
Dora Nomikos, Liting Zhu, Karen A. Gelmon, Prashanth Reddy Moku, E. Scott Halstead, Samuel Aparicio, Joyson Poulose, Ashok Maddukuri, Kim Leitzel, Allan Lipton, Shakeel Virk, Vinod Nagabhairu, Todd Umstead, Howard Spiegel, Dan Mckeone, Bingshu E. Chen, Wendy R. Parulekar, Leah Cream, Lois E. Shepherd, Hyma Polimera, Suhail M. Ali, Neha Pancholy, Joseph J. Drabick, Aamnah Ali
Publikováno v:
Cancer. 126:4859-4866
Background The purpose of this retrospective biomarker study of the Canadian Cancer Trials Group (CCTG) MA.31 randomized phase 3 trial (lapatinib vs trastuzumab) of HER2-positive metastatic breast cancer (MBC) was to evaluate the prognostic and predi
Autor:
Suhail M. Ali, Hyma Polimera, Prashanth Reddy Moku, Liting Zhu, Aamnah Ali, Kim Leitzel, Samuel Aparicio, Karen A. Gelmon, Ashok Maddukuri, Bingshu E. Chen, Joyson Poulose, SE Halstead, Todd Umstead, WE Parulekar, Howard Spiegel, Neha Pancholy, Leah Cream, Lois E. Shepherd, D Mckeone, Joseph J. Drabick, Dora Nomikos, Allan Lipton, Shakeel Virk, Vinod Nagabhairu
Publikováno v:
Cancer Research. 79:PD3-10
Background: In the CCTG (Canadian Clinical Trials Group) MA.31 randomized phase 3 trial, the trastuzumab-taxane combination led to longer PFS than lapatinib-taxane in HER2-positive metastatic breast cancer (MBC). We previously reported the prognostic
Autor:
Hyma Vani Polimera, Mark Pomerantz, Kim Leitzel, Subrina Farah, Wanling Xie, John A. Steinharter, Grace Shaw, Suhail M. Ali, Joseph J. Drabick, Harry Menon, Matthew Bartock, Neal Shah, Prashanth Moku, Neha Pancholy, Ashok Maddukuri, E. Scott Halstead, Todd Umstead, Daniel Mckeone, Howard Spiegel, A. Lipton
Publikováno v:
SSRN Electronic Journal.
Autor:
Joseph J. Drabick, Grace Shaw, Matthew Bartock, Suhail M. Ali, Mark Pomerantz, Subrina Farah, Ashok Maddukuri, Kim Leitzel, Harry Menon, John A. Steinharter, Daniel Mckeone, E. Scott Halstead, Hyma Polimera, Neha Pancholy, Wanling Xie, Neal Shah, Todd Umstead, Howard Spiegel, Prashanth Reddy Moku, Allan Lipton
Publikováno v:
Journal of Clinical Oncology. 38:e17565-e17565
e17565 Background: We previously reported the significant prognostic and predictive utility of pretreatment serum PD-L1 in the CCTG MA.31 breast cancer serum bank (SABCS 2018, abstr PD3-10). IL-8 (CXCL8) is a pro-inflammatory cytokine that binds to C
Autor:
Suhail M. Ali, Scott Halstead, Daniel Mckeone, Kim Leitzel, Hyma Polimera, Allan Lipton, Ashok Maddukuri, Joyson Poulose, Prashanth Reddy Moku, Todd Umstead, Howard Spiegel, Harry Menon, Vinod Nagabhairu, Aamnah Ali, Joseph J. Drabick, Neha Pancholy
Publikováno v:
Journal of Clinical Oncology. 37:4131-4131
4131 Background: We previously reported the prognostic and predictive utility of pretreatment serum PD-L1 in the CCTG MA.31 serum bank (SABCS 2018, abstr PD3-10). IL-8 (CXCL8) is a pro-inflammatory cytokine that binds to CXCR1 and CXCR2 and promotes
Autor:
Samuel Aparicio, Joyson Poulose, Ashok Maddukuri, Dora Nomikos, Hyma Polimera, E. Scott Halstead, Suhail M. Ali, Urmeel Hasmukh Patel, Wendy R. Parulekar, Bingshu E. Chen, Leah Cream, Lois E. Shepherd, Howard Spiegel, Liting Zhu, Karen A. Gelmon, Aamnah Ali, Allan Lipton, Shakeel Virk, Joseph J. Drabick, Kim Leitzel
Publikováno v:
Journal of Clinical Oncology. 36:1031-1031
1031Background: In MA.31 the lapatinib-taxane combination led to shorter PFS than trastuzumab-taxane in HER2+ metastatic breast cancer. We previously reported the positive prognostic utility of pre...
Autor:
Francisco J. Esteva, E. Scott Halstead, Ayesha Ali, Allan Lipton, Howard Spiegel, Kim Leitzel, Robert Evans, Suhail M. Ali, Wolfgang J. Köstler, Joseph J. Drabick, Eric I Marks, Laura Krecko, Vinod Nagabhairu, Angelique Ellerbee Richardson, Hyma Vani Polimera
Publikováno v:
Journal of Clinical Oncology. 35:1024-1024
1024 Background: Recently the immune checkpoint inhibitors (ICIs) have demonstrated efficacy across a wide variety of cancers, but have been less effective in breast cancer. PD-L1 (B7-H1, CD274) is a ligand produced by many tumor cells and some immun